Guardant Health (GH) Gross Margin (2017 - 2026)

Guardant Health has disclosed Gross Margin across 10 years of filings, most recently posting 65.22% for Q1 2026.

• Gross Margin for Q1 2026 came in at 65.22%, up 194.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 71.19% (up 365.0% YoY), and the FY2025 annual result was 64.46%, up 367.0% from the prior year.
• Gross Margin came in at 65.22% for Q1 2026 at Guardant Health, down from 100.81% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 185.58% in Q4 2023 to a low of 31.54% in Q3 2022.
• The 5-year median for Gross Margin is 59.14% (2024), against an average of 63.08%.
• Across the five-year window, Gross Margin soared 14975 bps in 2023 and slumped 10026 bps in 2024, its largest moves.
• Guardant Health's Gross Margin stood at 35.83% in 2022, then jumped by 418 bps to 185.58% in 2023, then sank by 54 bps to 85.32% in 2024, then advanced by 18 bps to 100.81% in 2025, then plunged by 35 bps to 65.22% in 2026.
• The last three Gross Margin figures came in at 65.22% (Q1 2026), 100.81% (Q4 2025), and 51.97% (Q3 2025), per Business Quant data.